About Medicis Pharmaceutical (NYSE:MRX)
Medicis Pharmaceutical Corporation (Medicis) together with its wholly owned subsidiaries is an independent specialty pharmaceutical company engaged in the development and marketing of products for the treatment of dermatological and aesthetic conditions in the United States and Canada. Medicis offers a range of products addressing various conditions or aesthetic improvements, including facial wrinkles. Its brands are DYSPORT (abobotulinumtoxinA) 300 Units for Injection, PERLANE Injectable Gel, RESTYLANE Injectable Gel, SOLODYN (minocycline HCl, USP) Extended Release Tablets, VANOS (fluocinonide) Cream 0.1%, ZIANA (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel and ZYCLARA (imiquimod) Cream 3.75% and 2.5%. As of December 31, 2011, it offered 27 branded products. On December 2, 2011, it acquired Graceway Pharmaceuticals, LLC (Graceway). On November 1, 2011, Medicis sold Medicis Technologies Corporation, formerly LipoSonix, Inc., to Solta Medical, Inc. (Solta).
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on EquityN/A
Return on AssetsN/A
Medicis Pharmaceutical (NYSE:MRX) Frequently Asked Questions
What is Medicis Pharmaceutical's stock symbol?
Medicis Pharmaceutical trades on the New York Stock Exchange (NYSE) under the ticker symbol "MRX."
Who are Medicis Pharmaceutical's key executives?
Medicis Pharmaceutical's management team includes the folowing people:
- Robert Roswell Chai-Onn, Executive Vice President, General Counsel, Secretary, Director (Age 44)
- Howard Bradley Schiller, Officer, Director (Age 53)
- Ryan Weldon, Officer, Director
Has Medicis Pharmaceutical been receiving favorable news coverage?
News coverage about MRX stock has been trending positive on Wednesday, Accern Sentiment Analysis reports. Accern identifies positive and negative news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Medicis Pharmaceutical earned a news sentiment score of 0.29 on Accern's scale. They also assigned headlines about the healthcare company an impact score of 45.18 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next several days.
How do I buy shares of Medicis Pharmaceutical?
Shares of MRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Medicis Pharmaceutical?
Medicis Pharmaceutical's mailing address is 8125 N Hayden Rd, SCOTTSDALE, AZ 85258-2463, United States. The healthcare company can be reached via phone at +1-212-5992000.
MarketBeat Community Rating for Medicis Pharmaceutical (MRX)MarketBeat's community ratings are surveys of what our community members think about Medicis Pharmaceutical and other stocks. Vote "Outperform" if you believe MRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
Medicis Pharmaceutical (NYSE:MRX) Analyst Ratings History
(Data available from 4/25/2016 forward)
|Date||Brokerage||Action||Rating||Price Target||Impact on Share Price||Details|
Medicis Pharmaceutical (NYSE:MRX) Earnings History and Estimates Chart
Medicis Pharmaceutical (NYSE MRX) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Medicis Pharmaceutical (NYSE:MRX) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Medicis Pharmaceutical (NYSE MRX) Insider Trading and Institutional Ownership History
Medicis Pharmaceutical (NYSE MRX) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
Medicis Pharmaceutical (NYSE MRX) News Headlines
Medicis Pharmaceutical (NYSE:MRX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Medicis Pharmaceutical (NYSE:MRX) Income Statement, Balance Sheet and Cash Flow Statement
Medicis Pharmaceutical (NYSE MRX) Stock Chart for Wednesday, April, 25, 2018